Home > Insider Trading > Filing (0001203311-20-000020)

Filing Details

Accession Number:: 0001203311-20-000020
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-06 18:32:38
Reporting Period:: 2020-05-04

Accepted Time:: 2020-05-06 18:32:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1060736	Seattle Genetics Inc	SGEN	Biological Products, (No Disgnostic Substances) (2836)	911874389

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1216477	E Todd Simpson	21823 30Th Drive Se Bothell WA 98021	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-04	14,167	$12.00	175,863	No	4	M	Direct
Common Stock	Disposition	2020-05-04	14,167	$147.00	161,696	No	4	S	Direct
Common Stock	Acquisiton	2020-05-05	26,867	$15.46	188,563	No	4	M	Direct
Common Stock	Disposition	2020-05-05	13,500	$162.45	175,063	No	4	S	Direct
Common Stock	Disposition	2020-05-05	12,167	$163.36	162,896	No	4	S	Direct
Common Stock	Disposition	2020-05-05	1,200	$164.10	161,696	No	4	S	Direct
Common Stock	Acquisiton	2020-05-05	1,103	$45.30	162,799	No	4	M	Direct
Common Stock	Acquisiton	2020-05-05	2,554	$39.15	165,353	No	4	M	Direct
Common Stock	Acquisiton	2020-05-05	2,268	$44.09	167,621	No	4	M	Direct
Common Stock	Acquisiton	2020-05-05	2,436	$41.04	170,057	No	4	M	Direct
Common Stock	Acquisiton	2020-05-05	3,831	$26.10	173,888	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Disposition	2020-05-05	3,831	$0.00	3,831	$26.10
Common Stock	Incentive Stock Option (right to buy)	Disposition	2020-05-05	2,554	$0.00	2,554	$39.15
Common Stock	Incentive Stock Option (right to buy)	Disposition	2020-05-05	2,436	$0.00	2,436	$41.04
Common Stock	Incentive Stock Option (right to buy)	Disposition	2020-05-05	2,268	$0.00	2,268	$44.09
Common Stock	Incentive Stock Option (right to buy)	Disposition	2020-05-05	1,103	$0.00	1,103	$45.30
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-05-04	14,167	$0.00	14,167	$12.00
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-05-05	26,867	$0.00	26,867	$15.46

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2022-08-20	No	4	M	Direct
2025-08-25	No	4	M	Direct
2023-08-19	No	4	M	Direct
2024-08-26	No	4	M	Direct
2026-08-27	No	4	M	Direct
2020-08-27	No	4	M	Direct
2021-08-24	No	4	M	Direct

Footnotes

Reflects sales of common stock executed in multiple transactions at prices ranging from $147.00 to $147.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $162.00 to $162.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $163.00 to $163.93. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $164.00 to $164.18. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the shares were fully vested on 8/20/16.
Options vested at a rate of 25% on 8/25/16 and monthly thereafter until all the shares were fully vested on 8/25/19.
Options vested at a rate of 25% on 8/19/14 and monthly thereafter until all the shares were fully vested on 8/19/17.
Options vested at a rate of 25% on 8/26/15 and monthly thereafter until all the shares were fully vested on 8/26/18.
Options vested at a rate of 25% on 8/27/17 and then monthly thereafter. All the shares shall be fully vested on 8/27/20.
Options vested at a rate of 25% on 8/27/11 and monthly thereafter until all the shares were fully vested on 8/27/14.
Options vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/24/15.